Home > Journals > The Quarterly Journal of Nuclear Medicine and Molecular Imaging > Past Issues > The Quarterly Journal of Nuclear Medicine 1999 September;43(3) > The Quarterly Journal of Nuclear Medicine 1999 September;43(3):217-23

CURRENT ISSUE
 

ARTICLE TOOLS

Reprints

THE QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

A Journal on Nuclear Medicine and Molecular Imaging


A Journal on Nuclear Medicine and Molecular Imaging
Affiliated to the Society of Radiopharmaceutical Sciences and to the International Research Group of Immunoscintigraphy
Indexed/Abstracted in: Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index (SciSearch), Scopus
Impact Factor 2,481


eTOC

 

  ENDOCRINOLOGY - I
Diagnostic procedures
FREEfree


The Quarterly Journal of Nuclear Medicine 1999 September;43(3):217-23

Copyright © 2000 EDIZIONI MINERVA MEDICA

language: English

Nuclear medicine imaging of pheochromocytoma and neuroblastoma

Sisson J. C., Shulkin B. L.

From the Division of Nuclear Medicine Department of Internal Medicine University of Michigan Health Systems, Ann Arbor, Michigan, USA


FULL TEXT  


Both phe­och­rom­o­cy­tomas and neu­ro­blas­tomas can now be iden­ti­fied and ­located ­with a ­high ­level of accu­racy. Scin­tig­raphy ­with ­MIBG has ­become an indis­pens­able diag­nostic ­method for ­defining the ­extent and loca­tion of ­many if not ­most phe­och­rom­o­cy­tomas. To ­define the ­stage, to doc­u­ment the ­course and to eval­uate the ­response to ther­a­pies in ­patients ­with neu­ro­blas­toma, ­imaging ­with ­MIBG is now essen­tial.

top of page

Publication History

Cite this article as

Corresponding author e-mail